BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 233445)

  • 1. [Are serum acid phosphatase levels of diagnostic significance in prostatic cancer? (author's transl)].
    Bollack C; Helwig JJ; Offner M
    Sem Hop; 1979 Dec 18-25; 55(43-44):2022-6. PubMed ID: 233445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostatic acid phosphatase and prostate-specific antigen in prostate cancer.
    Kuriyama M; Loor R; Wang MC; Lee C; Killian CS; Papsidero LD; Inaji H; Nishiura T; Slack NH; Murphy GP; Chu TM
    Int Adv Surg Oncol; 1982; 5():29-49. PubMed ID: 6178696
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer].
    Bauer HW
    Med Welt; 1982 Nov; 33(46):1616-21. PubMed ID: 6185820
    [No Abstract]   [Full Text] [Related]  

  • 5. Early detection of prostatic cancer by radioimmunoassay for prostatic acid phosphatase.
    Med Lett Drugs Ther; 1979 Nov; 21(22):90-1. PubMed ID: 492069
    [No Abstract]   [Full Text] [Related]  

  • 6. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnostic value of the radioimmunological estimation of prostatic acid phosphatase. Comparative value of the measurement of enzyme activity (author's transl)].
    Tellier JL; Chatal JF; Bourdin S; Auvigne J; Etienne P; Faye R
    J Urol (Paris); 1981; 87(3):169-73. PubMed ID: 7240777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoreactive prostate-specific acid phosphatase in prostatic cancer.
    Kontturi M; Vihko P; Lukkarinen O; Vihko R
    Scand J Clin Lab Invest Suppl; 1985; 179():67-74. PubMed ID: 3866311
    [No Abstract]   [Full Text] [Related]  

  • 9. Acid phosphatase.
    Henneberry MO; Engel G; Grayhack JT
    Urol Clin North Am; 1979 Oct; 6(3):629-41. PubMed ID: 388794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum prostatic acid phosphatase].
    Chen M; Gai M; Fishelovitz J; Hegesh E
    Harefuah; 1983 May; 104(9):378-80. PubMed ID: 6674043
    [No Abstract]   [Full Text] [Related]  

  • 11. [New prospective diagnostic serum markers in prostatic cancer].
    Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
    Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
    [No Abstract]   [Full Text] [Related]  

  • 12. The efficacy of serum prostate specific antigen as a tumour marker in prostatic carcinoma: a comparison with serum acid phosphatase.
    Cooke RR; Nacey JN; Beeston RE; Delahunt B
    N Z Med J; 1992 Sep; 105(941):345-7. PubMed ID: 1279493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzymological study of prostatic cancer VIII. Comparison of acid phosphatase by measurement of enzymatic level and radioimmunoassay in diagnosis of patients with prostatic carcinoma (author's transl)].
    Ishibe T
    Nihon Hinyokika Gakkai Zasshi; 1980 Dec; 71(12):1484-8. PubMed ID: 6164809
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cancer of the prostate: prostatic acid phosphatases. Biochemical properties and assay].
    Jardillier JC; Desoize B; Delvincourt C
    Bull Cancer; 1985; 72(6):519-26. PubMed ID: 3912016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results].
    Bauer HW; Schmiedt E
    Urologe A; 1983 Sep; 22 Suppl():367-71. PubMed ID: 6195796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunoassay for prostatic acid phosphatase in human serum. Methodologic aspects (author's transl)].
    Pradalier N; Canal P; Pujol A; Fregevu Y; Soula G
    Ann Biol Clin (Paris); 1982; 40(1):45-50. PubMed ID: 7200750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of prostatic acid phosphatase (PAP), tissue polypeptide antigen (TPA), CA-50, neopterine and of osteocalcin in patients with prostatic carcinoma.
    Lewenhaupt A; Ekman P; Eneroth P; Eriksson A; Nordström L
    Scand J Clin Lab Invest Suppl; 1985; 179():75-80. PubMed ID: 3878574
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prostatic acid phosphatase and prostatic specific antigen measured by immunoenzyme assay].
    Fuse H; Akimoto S; Shimazaki J
    Hinyokika Kiyo; 1986 Dec; 32(12):1813-9. PubMed ID: 2435130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic acid phosphatase. Biomolecular features and assays for serum determination.
    Romas NA; Kwan DJ
    Urol Clin North Am; 1993 Nov; 20(4):581-8. PubMed ID: 8273266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the serum concentration of prostate-specific antigen as a biological marker in the evolution of disseminated prostatic cancer].
    Morote Robles J; de Torres Mateos JA; Soler-Roselló A
    Actas Urol Esp; 1988; 12(2):152-7. PubMed ID: 2458015
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.